Related Experiment Videos

Reply to Fišer et al.: Myeloid reprogramming of Ph+ B-ALL: A potential therapeutic strategy

Ravindra Majeti1, Christopher Dove2, James Scott McClellan2

  • 1Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305 rmajeti@stanford.edu.

Proceedings of the National Academy of Sciences of the United States of America
|June 13, 2015
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos